Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in Type 2 Diabetes and Chronic Kidney Disease (FIVE-STAR)
Latest Information Update: 13 Feb 2024
At a glance
- Drugs Finerenone (Primary)
- Indications Renal failure; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms FIVE-STAR
Most Recent Events
- 06 Feb 2024 Status changed from recruiting to active, no longer recruiting.
- 22 Aug 2023 Status changed from not yet recruiting to recruiting.
- 07 Jun 2023 New trial record